The role of CD44 and matrix metalloproteinase-9 expression in predicting neck metastasis of supraglottic laryngeal carcinoma

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 32, Issue 2, 2011, Pages 141-146

  Yüce, Imdat ^a   Bayram, Ali ^a   Çaǧli, Sedat ^a   Canöz, Özlem ^a   Bayram, Sevgi ^a   Güney, Ercihan ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; GELATINASE B; HERMES ANTIGEN; PARAFFIN; STREPTAVIDIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; DISEASE MARKER; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; SUPRAGLOTTIC LARYNX CARCINOMA;

ANTIGENS, CD44; CASE-CONTROL STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952317223     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjoto.2010.01.001     Document Type: Article

References (28)

1. Xie M, Sun Y, Li Y. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases. Laryngoscope 2004;114:2243-8. (Pubitemid 39602498)
2. Cagli S, Yuce I, Yiǧitbasí OG, et al. Is routine bilateral neck dissection absolutely necessary in the management of N0 neck in patients with supraglottic carcinoma? Eur Arch Otorhinolaryngol 2007;264:1453-7.
3. Takes RP, Rinaldo A, Rodrigo JP, et al. Can biomarkers play a role in the decision about treatment of the clinically negative neck in patients with head and neck cancer? Head Neck 2008;30:525-38.
4. Bajorath J. Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Proteins 2000;39:103-11. (Pubitemid 30176478)
5. Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 1999;13:35-48. (Pubitemid 29045114)
6. Masuda M, Kuratomi Y, Shiratsuchi H, et al. Decreased CD44H expression in early-stage tongue carcinoma associates with late nodal metastases following interstitial brachytherapy. Head Neck 2000;22:662-5.
7. Wang SL, Yang Q, Xiao BK, et al. Expression of CD44s and CD44v6 in laryngeal squamous cell carcinoma and their significance. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2000;14:446-8.
8. Kawano T, Nakamura Y, Yanoma S, et al. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer. Auris Nasus Larynx 2004;31:35-41. (Pubitemid 38369373)
9. Rosenthal EL, Matrisian LM. Matrix metalloproteases in head and neck cancer. Head Neck 2006;28:639-48. (Pubitemid 44025114)
10. Liu WW, Zeng ZY, Wu QL, et al. Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Otolaryngol Head Neck Surg 2005;132:395-400.
11. de Vicente JC, Fresno MF, Villalain L, et al. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase- 9 in oral squamous cell carcinoma. Oral Oncol 2005;41:283-93. (Pubitemid 40311757)
12. Hong SD, Hong SP, Lee JI, et al. Expression of matrix metalloproteinase- 2 and -9 in oral squamous cell carcinoma with regard to the metastatic potential. Oral Oncol 2000;36:207-13.
13. Ruokolainen H, Pääkkö P, Turpeenniemi-Hujanen T. Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis. Clin Cancer Res 2004;10:3110-6. (Pubitemid 38619691)
14. Kosunen A, Pirinen R, Ropponen K, et al. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma. Oral Oncol 2007;43:51-9. (Pubitemid 46162248)
15. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.
16. Altinel M, Arpali E, Turhan N, et al. Increased expression of CD44s in conventional renal cell carcinomas with renal vein or vena cava thrombosis. a retrospective evaluation of the expression of CD44s by immunohistochemical analysis in conventional RCC patients and in conventional RCC patients with renal vein or vena cava thrombosis. Urol Int 2008;81:452-5.
17. Vasala K, Pääkko P, Turpeenniemi-Hujanen T. Matrix metalloproteinase-9 (MMP-9) immunoreactive protein in urinary bladder cancer: a marker of favorable prognosis. Anticancer Res 2008;28:1757-61.
18. Laverick S, Lowe D, Brown JS, et al. The impact of neck dissection on health-related quality of life. Arch Otolaryngol Head Neck Surg 2004;130:149-54. (Pubitemid 38182538)
19. Buckley JG, MacLennan K. Cervical node metastases in laryngeal and hypopharyngeal cancer: a prospective analysis of prevalence and distribution. Head Neck 2000;22:380-5. (Pubitemid 30413304)
20. Genden EM, Ferlito A, Bradley PJ, et al. Neck disease and distant metastases. Oral Oncol 2003;39:207-12. (Pubitemid 36255686)
21. Knappe M, Louw M, Gregor RT. Ultrasonography-guided fine-needle aspiration for the assessment of cervical metastases. Arch Otolaryngol Head Neck Surg 2000;126:1091-6.
22. Bernards R, Weinberg RA. A progression puzzle. Nature 2002;418:823. (Pubitemid 34966286)
23. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996;3:895-904. (Pubitemid 27017088)
24. McCawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 2000;6:149-56. (Pubitemid 30171365)
25. Westermarck J, Kähäri VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999;13:781-92. (Pubitemid 29220691)
26. Hidalgo M, Eckhardt SG. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 2001;93:178-93. (Pubitemid 32166488)
27. O-Charoenrat P, Rhys-Evans PH, Eccles SA. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2001;127:813-20. (Pubitemid 32619361)
28. Kurahara S, Shinohara M, Ikebe T, et al. Expression of MMPS, MTMMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 1999;21:627-38.